311 related articles for article (PubMed ID: 25914777)
1. Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.
Koplay M; Sivri M; Erdogan H; Nayman A
World J Hepatol; 2015 Apr; 7(5):769-76. PubMed ID: 25914777
[TBL] [Abstract][Full Text] [Related]
2. Radiologic evaluation of nonalcoholic fatty liver disease.
Lee SS; Park SH
World J Gastroenterol; 2014 Jun; 20(23):7392-402. PubMed ID: 24966609
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
Zhou JH; Cai JJ; She ZG; Li HL
World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.
Jayakumar S; Harrison SA; Loomba R
Curr Hepatol Rep; 2016 Jun; 15(2):86-95. PubMed ID: 27795938
[TBL] [Abstract][Full Text] [Related]
5. Current status of imaging in nonalcoholic fatty liver disease.
Li Q; Dhyani M; Grajo JR; Sirlin C; Samir AE
World J Hepatol; 2018 Aug; 10(8):530-542. PubMed ID: 30190781
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
[TBL] [Abstract][Full Text] [Related]
7. Advances in ultrasound elastography for nonalcoholic fatty liver disease.
Yoneda M; Honda Y; Nogami A; Imajo K; Nakajima A
J Med Ultrason (2001); 2020 Oct; 47(4):521-533. PubMed ID: 32748075
[TBL] [Abstract][Full Text] [Related]
8. Advances in noninvasive methods for diagnosing nonalcoholic fatty liver disease.
Shen FF; Lu LG
J Dig Dis; 2016 Sep; 17(9):565-571. PubMed ID: 27429213
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM; Loomba R; Anstee QM; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Goodman ZD; Chalasani NP; Kowdley KV; George J; Lindor K
Hepatology; 2018 Jul; 68(1):349-360. PubMed ID: 29222917
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: new trends and role of ultrasonography.
Tada T; Nishimura T; Yoshida M; Iijima H
J Med Ultrason (2001); 2020 Oct; 47(4):511-520. PubMed ID: 33089412
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.
Tsai E; Lee TP
Clin Liver Dis; 2018 Feb; 22(1):73-92. PubMed ID: 29128062
[TBL] [Abstract][Full Text] [Related]
12. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
Castera L; Friedrich-Rust M; Loomba R
Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
[TBL] [Abstract][Full Text] [Related]
14. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).
Drescher HK; Weiskirchen S; Weiskirchen R
Cells; 2019 Aug; 8(8):. PubMed ID: 31394730
[TBL] [Abstract][Full Text] [Related]
15. [New advances in diagnosis of nonalcoholic fatty liver disease].
Qu Y; Lu L
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):85-8. PubMed ID: 26983472
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Hannah WN; Harrison SA
Hepatology; 2016 Dec; 64(6):2234-2243. PubMed ID: 27338123
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
Papatheodoridi M; Cholongitas E
Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive biomarkers for the diagnosis of steatohepatitis and advanced fibrosis in NAFLD.
Pearce SG; Thosani NC; Pan JJ
Biomark Res; 2013 Feb; 1(1):7. PubMed ID: 24252302
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease.
Jayasekera D; Hartmann P
World J Hepatol; 2023 May; 15(5):609-640. PubMed ID: 37305367
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease.
Mansoor S; Collyer E; Alkhouri N
Curr Gastroenterol Rep; 2015 Jun; 17(6):23. PubMed ID: 26031832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
